Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Key Stock Data
The current last sale of $2.80 is 107.41% Higher than the 52 week low.
|Intraday||Last 52 Weeks|
|High:||$ 2.80||$ 13|
|Low:||$ 2.671||$ 1.35|
Company Description (as filed with the SEC)
We are a clinical-stage biopharmaceutical company focused on developing novel therapeutics for immune-mediated diseases in adults and children. We are using our proprietary immunomodulatory platform technology -- a high concentration, stabilized formulation of hypochlorous acid, or HOCl -- to develop prescription, topical drugs for the treatment of Atopic Dermatitis, or AD, and other dermatological indications, including Acne Vulgaris, or common Acne, Psoriasis and certain additional indications. Our lead product candidate, PR022, is a non-alcohol based topical gel containing the active ingredient HOCl for the treatment of AD that is in a Phase 2 clinical trial, from which we expect to report top-line data in the third quarter of 2018. Our platform technology, as demonstrated by pre-clinical studies, has the ability to modulate key cytokines that are implicated in multiple dermatological conditions. ... More ...
Nasdaq Official Price
Jun. 24, 2019
Jun. 24, 2019